Hee Gyung Kang Selected Research

Critical Illness (Critically Ill)

11/2018	Acute kidney injury and continuous renal replacement therapy in children; what pediatricians need to know.
1/2018	Factors affecting serum concentration of vancomycin in critically ill oliguric pediatric patients receiving continuous venovenous hemodiafiltration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hee Gyung Kang Research Topics

Disease

19	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2024 - 08/2011
12	Proteinuria 03/2024 - 11/2005
11	Chronic Renal Insufficiency 03/2024 - 11/2006
8	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 07/2017 - 03/2007
7	Chronic Kidney Failure (Chronic Renal Failure) 06/2020 - 07/2002
6	Atypical Hemolytic Uremic Syndrome 07/2023 - 09/2009
5	Glomerulonephritis 01/2023 - 01/2016
5	Hypertension (High Blood Pressure) 11/2020 - 03/2017
4	Renal Insufficiency (Renal Failure) 12/2023 - 07/2013
4	Disease Progression 12/2023 - 03/2007
4	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 02/2014
3	Bartter Syndrome (Syndrome, Bartter) 01/2023 - 08/2010
3	Kidney Diseases (Kidney Disease) 01/2023 - 04/2020
3	Hyperkalemia 02/2022 - 02/2011
3	Urinary Tract Infections (Urinary Tract Infection) 01/2022 - 12/2013
3	Infections 12/2021 - 04/2011
3	Water Intoxication 12/2020 - 12/2011
3	Dent Disease 11/2014 - 04/2005
2	Hypophosphatemia 06/2023 - 12/2011
2	Thrombocytopenia (Thrombopenia) 01/2023 - 01/2019
2	Hemolytic Anemia 01/2023 - 01/2019
2	Nephrocalcinosis 04/2022 - 01/2017
2	Acidosis 02/2022 - 03/2017
2	Sensorineural Hearing Loss 01/2022 - 07/2017
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2022 - 03/2017
2	Hearing Loss (Hearing Impairment) 01/2022 - 06/2010
2	Enteritis 12/2021 - 02/2014
2	Rare Diseases (Rare Disease) 12/2021 - 03/2017
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2021 - 06/2015
2	Body Weight (Weight, Body) 12/2020 - 01/2019
2	Hemorrhage 12/2020 - 01/2019
2	Inborn Genetic Diseases (Disease, Hereditary) 12/2020 - 01/2018
2	Hyperuricemia 11/2020 - 12/2011
2	Hemolytic-Uremic Syndrome 11/2020 - 02/2014
2	Hypotension (Low Blood Pressure) 08/2020 - 08/2010
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 01/2019
2	Viremia 08/2019 - 04/2019
2	Dehydration (Water Stress) 12/2018 - 02/2011
2	Critical Illness (Critically Ill) 11/2018 - 01/2018
2	Nephrolithiasis 02/2017 - 04/2005
2	Thrombosis (Thrombus) 05/2016 - 11/2006
2	Peritonitis 02/2014 - 06/2010
2	Inflammation (Inflammations) 07/2013 - 06/2010
2	Alkalosis 01/2011 - 08/2010
2	Hyperaldosteronism (Conn Syndrome) 01/2011 - 08/2010
1	Type 2 Diabetes Mellitus (MODY) 03/2024
1	Breakthrough Infections 01/2024
1	Portal Hypertension 12/2023
1	Osteochondrodysplasias (Spondyloepiphyseal Dysplasia) 12/2023
1	Diabetic Nephropathies (Diabetic Nephropathy) 10/2023
1	Congenital Abnormalities (Deformity) 06/2023
1	Rickets (Rachitis) 06/2023
1	Drug-Related Side Effects and Adverse Reactions 06/2023

Drug/Important Bio-Agent (IBA)

14	SteroidsIBA 12/2023 - 11/2006
5	CreatinineIBA 03/2024 - 11/2009
5	Rituximab (Mabthera)FDA Link 09/2023 - 08/2014
5	ReninIBA 02/2022 - 02/2011
4	SaltsIBA 06/2023 - 01/2011
3	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2011
3	CholesterolIBA 12/2023 - 01/2019
3	Hemoglobins (Hemoglobin)IBA 10/2023 - 01/2019
3	AntibodiesIBA 01/2023 - 11/2005
3	hydroxide ionIBA 12/2020 - 07/2013
3	Biomarkers (Surrogate Marker)IBA 04/2020 - 02/2012
2	Angiotensin Receptor AntagonistsIBA 03/2024 - 01/2022
2	Immunoglobulin G (IgG)IBA 01/2024 - 01/2016
2	Complement Inactivating AgentsIBA 07/2023 - 01/2021
2	ravulizumabIBA 07/2023 - 01/2021
2	Vitamin D FDA LinkGeneric 06/2023 - 07/2013
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2023 - 06/2019
2	ChloridesIBA 01/2023 - 08/2010
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2020
2	MineralsIBA 01/2023 - 01/2023
2	PotassiumIBA 01/2023 - 02/2022
2	SodiumIBA 01/2023 - 08/2010
2	GlucocorticoidsIBA 01/2023 - 06/2019
2	beta-Lactamases (beta-Lactamase)IBA 01/2022 - 11/2019
2	coenzyme Q10 (CoQ10)IBA 01/2022 - 07/2017
2	ubiquinone 6IBA 01/2022 - 07/2017
2	Complement System Proteins (Complement)IBA 12/2021 - 01/2019
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 12/2011
2	Retinaldehyde (Retinal)IBA 12/2020 - 07/2015
2	rasburicase (Elitek)FDA Link 11/2020 - 12/2011
2	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 01/2019
2	Serum AlbuminIBA 01/2019 - 01/2019
2	Monoclonal AntibodiesIBA 11/2018 - 08/2015
2	Complement Factor H (Factor H)IBA 01/2018 - 09/2009
1	finerenoneIBA 03/2024
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2024
1	Mineralocorticoid Receptor AntagonistsIBA 03/2024
1	Calcineurin InhibitorsIBA 01/2024

Therapy/Procedure

13	Therapeutics 06/2023 - 11/2011
7	Kidney Transplantation 12/2023 - 01/2011
5	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2023 - 07/2002
4	Transplantation 01/2023 - 04/2019
2	Length of Stay 01/2022 - 11/2020
2	Organ Transplantation 08/2019 - 03/2017
2	Renal Dialysis (Hemodialysis) 01/2019 - 12/2018
2	Drug Therapy (Chemotherapy) 01/2019 - 12/2011
2	Continuous Renal Replacement Therapy 11/2018 - 01/2018